These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 4170420)
1. Effects of an anti-androgen, SH 714 (6-chlor-delta-6-1, 2-alpha-methylen-17-alpha-hydroxyprogesterone acetate, cyproterone acetate) on canine prostatic hyperplasia. Neri RO; Casmer C; Zeman WV; Fielder F; Tabachnick II Endocrinology; 1968 Feb; 82(2):311-7. PubMed ID: 4170420 [No Abstract] [Full Text] [Related]
2. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma. Leav I; Schelling KH; Adams JY; Merk FB; Alroy J Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344 [TBL] [Abstract][Full Text] [Related]
3. Relationship between prostatic atrophy and apoptosis in the canine spontaneous benign prostatic hyperplasia (BPH) following chlormadinone acetate (CMA). Murakoshi M; Ikeda R; Fukui N; Nakayama T Tokai J Exp Clin Med; 2001 Jul; 26(2):71-5. PubMed ID: 11806444 [TBL] [Abstract][Full Text] [Related]
4. Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride. Shibata Y; Fukabori Y; Ito K; Suzuki K; Yamanaka H J Urol; 2001 Jan; 165(1):289-93. PubMed ID: 11125427 [TBL] [Abstract][Full Text] [Related]
5. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma. Leav I; Schelling KH; Adams JY; Merk FB; Alroy J Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337 [TBL] [Abstract][Full Text] [Related]
6. Effect of antiandrogen, chlormadinone acetate (CMA), in canine spontaneous benign prostatic hyperplasia (BPH). Murakoshi M; Ikada R; Tagawa M; Nakayama T Tokai J Exp Clin Med; 2000 Apr; 25(1):11-4. PubMed ID: 11023050 [TBL] [Abstract][Full Text] [Related]
7. The effect of the steroidal androgen receptor antagonist, Win 49,596, on the prostate and testis of beagle dogs. Juniewicz PE; McCarthy M; Lemp BM; Barbolt TA; Shaw C; Hollenbaugh DM; Winneker RC; Reel JR; Batzold FH Endocrinology; 1990 May; 126(5):2625-34. PubMed ID: 1691701 [TBL] [Abstract][Full Text] [Related]
8. Morphometric analysis of prostates in castrated dogs after treatment with androstanediol, estradiol, and cyproterone acetate. Tunn UW; Schüring B; Senge T; Neumann F; Schweikert HU; Rohr HP Invest Urol; 1981 Jan; 18(4):289-92. PubMed ID: 6161104 [TBL] [Abstract][Full Text] [Related]
9. Androgen and prostatic stroma. Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998 [TBL] [Abstract][Full Text] [Related]
10. Immunolocalization of androgen receptor in canine prostatic hyperplasia--effect of antiandrogen. Murakoshi M; Ikeda R; Tagawa M; Nakayama T; Honma S; Mieda M Tokai J Exp Clin Med; 1998 Nov; 23(5):209-12. PubMed ID: 10418722 [TBL] [Abstract][Full Text] [Related]
11. Comparative effects and mechanisms of castration, estrogen anti-androgen, and anti-estrogen-induced regression of accessory sex organ epithelium and muscle. Neubauer B; Blume C; Cricco R; Greiner J; Mawhinney M Invest Urol; 1981 Jan; 18(4):229-34. PubMed ID: 7451082 [TBL] [Abstract][Full Text] [Related]
12. Cellular and extracellular behavior in the gerbil (Meriones unguiculatus) ventral prostate following different types of castration and the consequences of testosterone replacement. Oliveira SM; Leite Vilamaior PS; Corradi LS; Góes RM; Taboga SR Cell Biol Int; 2007 Mar; 31(3):235-45. PubMed ID: 17123842 [TBL] [Abstract][Full Text] [Related]
13. [Androgen deprivation in benign prostatic hypertrophy]. Tenaglia R; Nicolai M; Di Federico G; Iantorno R; Zezza A; Lombardi G J Urol (Paris); 1993; 99(6):296-8. PubMed ID: 7516371 [TBL] [Abstract][Full Text] [Related]
14. 4. Steroid pathophysiology of BPH. Correlative morphological and biochemical investigations on the stromal tissue of the human prostate. Bartsch G; Daxenbichler G; Rohr HP J Steroid Biochem; 1983 Jul; 19(1A):147-54. PubMed ID: 6193337 [TBL] [Abstract][Full Text] [Related]
15. Biochemical and histological studies on prostates in castrated dogs after treatment with androstanediol, oestradiol and cyproterone acetate. Tunn U; Senge T; Schenck B; Neumann F Acta Endocrinol (Copenh); 1979 Jun; 91(2):373-84. PubMed ID: 88858 [TBL] [Abstract][Full Text] [Related]
16. The effect of antiestrogen, antiandrogen, and the prolactin inhibitor 2 bromo-alpha-ergocriptine on the stromal tissue of human benign prostatic hyperplasia. Correlation of stereological data and plasma hormones. Bartsch G; Oberholzer M; Rohr HP Invest Urol; 1981 Jan; 18(4):308-12. PubMed ID: 6161105 [TBL] [Abstract][Full Text] [Related]
18. Effect of osaterone acetate administration on prostatic regression rate, peripheral blood hormone levels and semen quality in dogs with benign prostatic hypertrophy. Tsutsui T; Hori T; Shimizu M; Tatsuzawa C; Kawakami E J Vet Med Sci; 2001 Apr; 63(4):453-6. PubMed ID: 11346183 [TBL] [Abstract][Full Text] [Related]
19. The effects of osaterone acetate on clinical signs and prostate volume in dogs with benign prostatic hyperplasia. Socha P; Zduńczyk S; Tobolski D; Janowski T Pol J Vet Sci; 2018 Dec; 21(4):559-566. PubMed ID: 30605276 [TBL] [Abstract][Full Text] [Related]
20. Effects of cyproterone acetate on experimentally induced canine prostatic hyperplasia. A morphological and histochemical study. Tunn U; Senge T; Schenck B; Neumann F Urol Int; 1980; 35(2):125-40. PubMed ID: 6154989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]